![Tumor volume: a new prognostic factor of oncological outcome of localized clear cell renal cell carcinoma | BMC Cancer | Full Text Tumor volume: a new prognostic factor of oncological outcome of localized clear cell renal cell carcinoma | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-021-07795-8/MediaObjects/12885_2021_7795_Fig6_HTML.png)
Tumor volume: a new prognostic factor of oncological outcome of localized clear cell renal cell carcinoma | BMC Cancer | Full Text
![PDF) Development of the clinical calculator for mortality of patients with metastatic clear cell type renal cell carcinoma: An analysis of patients from Korean Renal Cancer Study Group database PDF) Development of the clinical calculator for mortality of patients with metastatic clear cell type renal cell carcinoma: An analysis of patients from Korean Renal Cancer Study Group database](https://i1.rgstatic.net/publication/341002310_Development_of_the_clinical_calculator_for_mortality_of_patients_with_metastatic_clear_cell_type_renal_cell_carcinoma_An_analysis_of_patients_from_Korean_Renal_Cancer_Study_Group_database/links/5ea9743b45851592d6a8a5df/largepreview.png)
PDF) Development of the clinical calculator for mortality of patients with metastatic clear cell type renal cell carcinoma: An analysis of patients from Korean Renal Cancer Study Group database
![A novel preoperative inflammatory marker prognostic score in patients with localized and metastatic renal cell carcinoma - ScienceDirect A novel preoperative inflammatory marker prognostic score in patients with localized and metastatic renal cell carcinoma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2214388217300450-gr2.jpg)
A novel preoperative inflammatory marker prognostic score in patients with localized and metastatic renal cell carcinoma - ScienceDirect
![Renal Cell Carcinoma: Cost of Treatment May Negate Impact of Treatment Advances - Cancer Therapy Advisor Renal Cell Carcinoma: Cost of Treatment May Negate Impact of Treatment Advances - Cancer Therapy Advisor](https://www.cancertherapyadvisor.com/wp-content/uploads/sites/12/2018/12/healthcarecostrenalcellcar_1358022.jpg)
Renal Cell Carcinoma: Cost of Treatment May Negate Impact of Treatment Advances - Cancer Therapy Advisor
![Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-019-49250-6/MediaObjects/41598_2019_49250_Fig2_HTML.png)
Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients
![The first competing risk survival nomogram in patients with papillary renal cell carcinoma | Scientific Reports The first competing risk survival nomogram in patients with papillary renal cell carcinoma | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-91217-z/MediaObjects/41598_2021_91217_Fig1_HTML.png)
The first competing risk survival nomogram in patients with papillary renal cell carcinoma | Scientific Reports
![PDF] Development of the clinical calculator for mortality of patients with metastatic clear cell type renal cell carcinoma: An analysis of patients from Korean Renal Cancer Study Group database | Semantic Scholar PDF] Development of the clinical calculator for mortality of patients with metastatic clear cell type renal cell carcinoma: An analysis of patients from Korean Renal Cancer Study Group database | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/503346139e7d62281fc955036b1fe2a70e2b4ab6/3-Table1-1.png)
PDF] Development of the clinical calculator for mortality of patients with metastatic clear cell type renal cell carcinoma: An analysis of patients from Korean Renal Cancer Study Group database | Semantic Scholar
![PDF] Development of the clinical calculator for mortality of patients with metastatic clear cell type renal cell carcinoma: An analysis of patients from Korean Renal Cancer Study Group database | Semantic Scholar PDF] Development of the clinical calculator for mortality of patients with metastatic clear cell type renal cell carcinoma: An analysis of patients from Korean Renal Cancer Study Group database | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/503346139e7d62281fc955036b1fe2a70e2b4ab6/5-Table3-1.png)
PDF] Development of the clinical calculator for mortality of patients with metastatic clear cell type renal cell carcinoma: An analysis of patients from Korean Renal Cancer Study Group database | Semantic Scholar
![Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-019-49250-6/MediaObjects/41598_2019_49250_Fig1_HTML.png)
Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients
![Frontiers | Using machine learning to predict lymph node metastasis in patients with renal cell carcinoma: A population-based study Frontiers | Using machine learning to predict lymph node metastasis in patients with renal cell carcinoma: A population-based study](https://www.frontiersin.org/files/MyHome%20Article%20Library/1104931/1104931_Thumb_400.jpg)
Frontiers | Using machine learning to predict lymph node metastasis in patients with renal cell carcinoma: A population-based study
![METTL14-mediated Lnc-LSG1 m6A modification inhibits clear cell renal cell carcinoma metastasis via regulating ESRP2 ubiquitination: Molecular Therapy - Nucleic Acids METTL14-mediated Lnc-LSG1 m6A modification inhibits clear cell renal cell carcinoma metastasis via regulating ESRP2 ubiquitination: Molecular Therapy - Nucleic Acids](https://www.cell.com/cms/asset/ecb4b074-cdf6-4b5e-93d6-203155f9d44a/fx1.jpg)
METTL14-mediated Lnc-LSG1 m6A modification inhibits clear cell renal cell carcinoma metastasis via regulating ESRP2 ubiquitination: Molecular Therapy - Nucleic Acids
![PDF] Development of the clinical calculator for mortality of patients with metastatic clear cell type renal cell carcinoma: An analysis of patients from Korean Renal Cancer Study Group database | Semantic Scholar PDF] Development of the clinical calculator for mortality of patients with metastatic clear cell type renal cell carcinoma: An analysis of patients from Korean Renal Cancer Study Group database | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/503346139e7d62281fc955036b1fe2a70e2b4ab6/4-Table2-1.png)